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Cel l-surface molecules are c ruc i a l i n lymphocyte growth con-
trol . S u c h molecules may funct ion as receptors for growth -
s t imu la t ing cytokines or may be associated w i th receptors a n d 
t ransmi t s ignals essent ia l for growth regulat ion. Receptor 
b lockade or removal of the s t imu la t ing cytokines may lead to 
decreased lymphocyte growth (Duke a n d C o h e n 1986). W i th -
drawal of in te r l euk ins slows h u m a n lymphocyte growth a n d 
Anal ly leads to the character is t ic form of "programmed cel l 
death" or apoptosis. Apoptos is is the most c ommon form of 
eukaryot ic cel l death and occurs i n embryogenesis, metamor-
phos is , t issue atrophy, a n d tumor regression. It is also i n -
duced by cytotoxic T lymphocytes a n d n a t u r a l k i l ler cel ls, by 
cytokines l ike tumor necrosis factor (TNF) a n d lymphotox in 
(LT), a n d by glucocort icoids. The most character ist ic s igns of 
apoptosis are segmentat ion of the nuc l eus , condensat ion of 
the cytop lasm, membrane b lebbing, a n d D N A fragmentat ion 
into mu l t imers of about 180 bp (called a D N A ladder) (see Kerr 
a n d H a r m o n , th is volume). To analyze mechan i sms of 
lymphocyte growth contro l a n d to interfere w i th the repl icat ion 
of l ympho id tumor cel ls, we ra ised monoc lona l ant ibodies 
against cel l-surface molecules involved i n these processes. 
Monoc lona l ant ibodies were u s u a l l y tested a n d selected by 
Apoptosis: The Molecular Basts of Cell Death 
Copyright 1991 Cold Spring Harbor Laboratory Press 0-87969-366-5/91 $3.00 + 00 87 
vir tue of their b ind ing to cel l-surface antigens of test cel ls. O u r 
a i m was to define reactive monoc lona l ant ibodies by funct iona l 
assays, namely by abrogat ion of growth of mal ignant test cells 
i n vitro. Monoc lona l ant ibodies were ra ised against the h u m a n 
B- lymphob las t cel l l ine SKW6 .4 . One monoc lona l ant ibody, 
an t i -APO-1 , showed the strongest funct ional activity a n d 
reacted w i th a n ant igen (APO-1) of - 5 0 k D on a set of act ivated 
h u m a n lymphocytes, on mal ignant h u m a n lymphocyte l ines, 
a n d on some patient-derived l eukemic cells. Ant i -APO-1 was of 
the IgG3/K isotype a n d h a d a h i gh affinity of K D = 1.9 x 1 0 " 1 0 . 
Despite m a n y cel l fusions under taken i n our laboratory, the 
hybr idoma w i th ant i -APO-1 activity has remained the only one 
i n about 25 ,000 tested. Nanogram quant i t ies of ant i -APO-1 
completely b locked prol i ferat ion of cells bear ing APO-1 i n vitro 
i n a manner character ist ic of apoptosis {Fig. 1). Ce l l death was 
preceded by changes i n cel l morphology a n d fragmentat ion of 
DNA . This process was d is t inct from ant ibody- and comple-
ment-dependent cel l lys is a n d was mediated by the ant ibody 
alone (Trauth et a l . 1989; K rammer 1989; K rammer et a l . 
1989; Köhler et a l . 1990). 
Purification of the APO-1 Antigen 
It was important to further characterize the APO-1 molecule 
w i th the a i m of l earn ing more about its funct ion. Therefore, we 
puri f ied the APO-1 ant igen from membranes of SKW6 .4 cel ls. 
The puri f ied APO-1 ant igen was found to be a glycoprotein 
w i th apparent M r of approximate ly 50 ,000 , w i th about 8000 of 
the M r accounted for by sugars. Pur i f ied APO-1 b locked an t i -
APO-1 - induced apoptosis of S K W 6 . 4 cells i n vitro, prov ing its 
serological identity w i th the APO-1-membrane ant igen. Large 
quanti t ies of the APO-1 ant igen enabled us to obta in a se-
quence of the APO-1 prote in. A computer search revealed that 
APO-1 was a new cell-surface ant igen. Moti fs i n the APO-1 se-
quence may provide u s w i th a c lue to the as yet elusive 
physio log ica l funct ion of the antigen. 
The APO-1-mediated Signal 
Induct ion of apoptosis was mediated by ant i -APO-1 alone a n d 
was complement- independent. Nevertheless, the F(ab ' ) 2 frag-
a n t i » A P O - l 240min a n t i - A P O - 1 24 h 
FIGURE 1 Induct ion of apoptosis of S K W 6 . 4 cel ls by an t i -APO-1 . The 
t ime of i n vitro i nduc t i on w i th contro l monoc lona l ant ibody or an t i -
APO-1 (1 ng/ml) is ind icated . 
ment of the IgG3 ant i -APO-1 d id not induce apoptosis. W h e n 
cross- l inked , however, by F ( a b ' ) 2 sheep ant i -mouse Ig an t i -
bodies, apoptosis was observed. To further s tudy the role of 
the Fc region of an t i -APO-1 , we isolated ant ibody c lass sw i tch 
var iants from the IgG3 ant i -APO-1-secret ing hyb r idoma cel l 
l ine. We obtained ant i -APO-1 ant ibodies of the IgG3, I g G l , 
IgG2b, IgG2a, a n d IgA isotypes. These ant ibodies showed the 
fol lowing effects: (1) a different degree of i nduc t i on of apoptosis 
of SKW6 .4 cells occurred i n the fol lowing order: IgG3, I g G l , 
IgG2a, IgA, IgG2b. (2) C ro s s - l i nk ing of the less effective c lass 
swi tch var iant IgG2b ant i -APO-1 by Prote in A showed the 
same degree of growth inh ib i t i on as IgG3 an t i -APO-1 . These 
resul ts suggested that induc t i on of apoptosis was dependent 
on c ross - l ink ing of the APO-1 cel l-surface ant igen. IgG3 ant i -
APO-1 b o u n d to the cel l surface might have self-aggregating 
capaci ty v ia Fc -Fc interact ions or b i n d to Fc receptors a n d 
therefore efficiently c ross - l ink the APO-1 ant igen. IgG2b an t i -
APO-1 might show fewer Fc -Fc interact ions, be a less efficient 
cross- l inker , a n d therefore be less effective i n induc t i on of 
apoptosis. C r o s s - l i n k i n g of APO-1 on the cel l membrane may 
be essent ial for APO-1-media ted s ignal t ransduc t i on across 
the membrane . 
We also asked whether interna l i zat ion of APO-1 and/or 
ant i -APO-1 might be a prerequisite for apoptosis i n our sys-
tem. The fol lowing exper iments suggested that th is is not the 
case. We chemica l ly coup led ant i -APO-1 to s i l i ca beads several 
t imes larger t han cells a n d incubated S K W 6 . 4 cells w i th these 
beads. We found that bead-coupled ant i -APO-1 was a n effi-
cient inducer of apoptosis i n SKW6 .4 cel ls. These resul ts re in-
force our assumpt i on that the APO-1 ant igen may produce a 
genuine t ransmembrane s ignal , the nature of w h i c h rema ins 
to be investigated. These resul ts also prompted u s to develop 
systems that might a l low u s to s tudy the ant i -APO-1 apoptosis 
process i n molecular terms. Thus , we looked for ce l lu lar sys-
tems that might be informative i n this respect. 
Selection of Cell Variants That Express the APO-1 Antigen but Are 
Resistant to Anti-APO-1 -induced Apoptosis 
After screening a large pane l of h u m a n B - a n d T-cel l l ines, we 
found that express ion of the APO-1 ant igen is a prerequisite, 
a l though not sufficient by itself for an t i -APO-1- induced cel l 
death. Thus , we identif ied several strongly A P O - 1 + cel l l ines 
res istant to an t i -APO-1- induced apoptosis. To s tudy this phe-
nomenon further, we selected several cel l var iants that differed 
i n the sensit iv i ty to an t i -APO-1 . The B-ce l l l ine SKW6 .4 (s IgM + , 
A P O - l + , sensit ive to 2 ng/ml ant i-APO-1) was cu l tu red w i th 
increas ing amounts of ant i -APO-1 for about 1 year. We ob-
ta ined a stable var iant that expressed the APO-1 ant igen bu t 
was res istant to at least 50 ng/ml an t i -APO-1 . In addi t ion, the 
T-cel l l ine C C R F was c loned under l im i t ing d i lu t i on condi t ions. 
Rep l i ca cu l tures of subc lones were screened for suscept ib i l i ty 
to an t i -APO-1 . Two subclones were selected that bo th ex-
pressed the APO-1 ant igen bu t differed i n sensit iv i ty to an t i -
APO-1 at least by a factor of 1000. It is conceivable that the 
mechan i sm of resistance to apoptosis i n SKW6 .4 a n d C C R F 
var iant cells is different. In any case, however, th is pair of cel l 
l ines shows very clearly that two requirements for an t i -APO-1 -
induced apoptosis are important : the cel l-surface express ion of 
the APO-1 ant igen a n d a n intact apoptosis s igna l pathway. We 
presume that these f indings may be of great future relevance 
to the putative use of the apoptosis concept i n tumor therapy. 
Apoptosis in Human T Lymphocytes 
Another informative set of cells w i th respect to the APO-1-me-
diated s ignal of apoptosis are no rma l h u m a n T lymphocytes . 
A l though we have data suggest ing that, i n contrast to rest ing 
B cells, activated B cells also undergo ant i -APO-1-mediated 
apoptosis, i n th is paper, we focus pr imar i l y on T cel ls. The m a -
jor i ty of no rma l h u m a n rest ing T lymphocytes do not express 
the APO-1 antigen. After act ivat ion, however, bo th the C D 4 + 
a n d C D 8 + subpopula t ions of T cells become positive for the 
APO-1 ant igen. A l though no signi f icant difference i n the 
amount of A P O - 1 + T cells a n d i n the epitope densi ty of APO-1 
antigens between T cells early (e.g., 1 day) or late (e.g., 6 days) 
after act ivat ion was observed, apoptosis was only induced by 
ant i -APO-1 i n the latter cel l popula t ion . Hence, the suscep-
t ibi l i ty for induc t i on of apoptosis i n act ivated T lymphocytes is 
dependent on the stage of differentiation of these cells. A com-
par i son of the set of A P O - 1 + T cells early or late after act ivat ion 
might help to elucidate the en igma of "death genes" involved i n 
ant i -APO-1-mediated apoptosis. In addi t ion , th is phenomenon 
might he lp to unde rs tand i n molecular terms the e l iminat ion 
of per iphera l T cells at the cessat ion of a n i m m u n e response. 
Anti-APO-1 -mediated Tumor Regression 
As d i scussed above, ant i -APO-1 induced apoptosis i n var ious 
T- a n d B-ce l l l ines i n vitro. Th is result led us to test the ant i -
APO-1 efficiency i n a n exper imental tumor system in vivo (Fig. 
2). The h u m a n B - l ymphoma l ine B J A B was chosen for these i n 
vivo experiments. Xenografts of th is l ine i n n u / n u mice were 
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FIGURE 2 An t i -APO-1-med ia t ed tumor regression of B J A B l ympho-
b las to id tumor xeno t ransp lants i n n u / n u mice. The p ic tures show 
prototype mice from each group, n u / n u mice w i th h u m a n B J A B l ym-
phob las to id tumors - 1 . 5 - 2 . 5 c m i n diameter (day 0) were i.v. injected 
w i th 500 isotype matched contro l monoc lona l ant ibody or an t i -
APO-1 ( IgG3 /K) on day 0. Mice w i th tumors were photographed 7 a n d 
14 days after monoc lona l ant ibody inject ion. 
previously shown to accumula te radiolabeled monoc lona l an t i -
bodies only i n the outer layer of the tumor , whereas centra l 
areas of nodules were v i r tua l ly inaccessible . U s i n g ant i -APO-1 
i n B J A B - b e a r i n g n u / n u mice, we asked three quest ions: (1) Is 
ant i -APO-1 as effective i n vivo as i n vitro? (2) Does ant i -APO-1 
affect the whole tumor despite preferential a c cumu la t i on i n 
the per iphery? (3) Does ant i -APO-1 -mediated tumor cel l death 
i n vivo alter the accessibi l i ty barr iers of the B J A B tumor? The 
resul ts were c lear-cut. Ant i -APO-1 ant ibodies, l ike a l l other 
antibodies tested, accumula t ed exclusively i n the per iphery of 
nodules even i f u p to 500 \ig of ant ibody was injected per 
mouse. Nevertheless, establ ished tumors - 1 . 5 - 2 . 5 c m i n 
diameter regressed i n 10/11 nude mice w i th in a few days. 
Histo logical t h in sect ions performed before complete tumor 
regression showed that as i n vitro, ant i -APO-1 also induced 
apoptosis i n vivo. The act ion of the ant ibody, however, d id not 
resul t i n a d is turbance of the accessib i l i ty barr ier . We con-
c luded from these experiments that tumors may be efficiently 
tack led by monoc lona l ant ibodies, par t i cu lar l y an t i -APO-1 , 
despite restr ic t ion of accessibi l i ty , provided the cytolytic ac-
tivity of the ant ibody is h i gh a n d the residence time of the 
ant ibody i n the tumor is long enough to "melt down" the tumor 
nodules from the outside (Trauth et a l . 1989). In addi t ion, the 
outcome of these experiments suggested that an t i -APO-1 - in -
duced apoptosis is a va l id concept wor th test ing for tumor 
treatment i n a c l in i ca l s i tuat ion , provided putative systemic 
toxicity of the ant ibody can be control led. 
One impor tant resul t s h o u l d be ment ioned at this point. In 
pre l iminary experiments, we tested the i n vivo therapeut ic ef-
ficiency of ant i -APO-1 on large SKW6 .4 tumors . In vitro ant i -
APO-1-sensi t ive (S) a n d -resistant (R) SKW6 .4 cells bo th ex-
press ing APO-1 on the cel l surface were grown to tumors of 
about 2 c m i n diameter i n S C I D mice. Ant i -APO-1 treatment of 
these an ima ls resul ted i n complete tumor regression of the 
S K W 6 . 4 S tumors only. A n i m a l s w i th S K W 6 . 4 R tumors were 
k i l l ed by the tumor . These resul ts suggested that two require-
ments for ant i -APO-1-mediated tumor regression by induc t i on 
of apoptosis also exist i n vivo: (1) express ion of the APO-1 
antigen and (2) a n intact apoptosis s ignal pathway. As already 
stated, these resul ts may have far-reaching impl icat ions for 
therapy u s i n g ra t iona l intervent ion strategies i n the c l in ic . 
Preclinical Applications of Apoptosis in the APO-1 System 
The above i n vivo experiments prompted u s to test APO-1 ex-
press ion i n var ious tumor systems a n d to test i n vitro indue-
t ion of apoptosis i n mal ignanc ies that may be candidates for 
future ant i -APO-1 treatment i n the c l in ic . 
Expression of the APO-1 antigen on acute lymphoblastic leuke-
mia cells. In T-acute l ymphoblas t i c l eukemia (ALL), APO-1 is 
expressed const i tut ively, especial ly i n cases corresponding to 
stages of very early T-cel l dif ferentiation. Ce l ls of the c ommon 
A L L phenotype represent ing the mal ignant precursors of B 
cel ls weakly express APO-1 i n a minor i ty of cases. However, i n 
these cells, APO-1 express ion is i nduced i n vitro by phorbo l 
myristate acetate (PMA) a n d cytokines s u c h as IL-4. In add i -
t ion, the const i tut ive express ion of APO-1 on pre-T-ALL cells is 
modula ted by mitogens a n d cytokines. The APO-1 ant igen may 
therefore be of importance for growth regulat ion i n mal ignant 
lymphocytes a n d may also serve a funct ion i n the development 
of no rma l precursor cel ls. In addi t ion , APO-1-posi t ive mal ig -
nan t cells may be a new subgroup of A L L a n d may be a target 
for APO-1-d i rec ted therapeut ic approaches i n vitro a n d i n vivo 
u s i n g the ant i -APO-1 ant ibody. 
Anti-APO-1 antibody-mediated apoptosis in adult T-cell leuke-
mia. We have descr ibed that the APO-1 ant igen is expressed 
on activated T cells a n d that sensit iv i ty to i nduc t i on of apopto-
sis by ant i -APO-1 is acquired d u r i n g long-term cu l ture of ac-
tivated T cells i n the presence of IL-2. S ince adu l t T-cel l leuke-
m i a (ATL) cel ls are the transformed counterpart of mature T 
lymphocytes, we were interested to see whether these cells ex-
press the APO-1 ant igen a n d whether they are sensitive to 
growth inh ib i t i on a n d induc t i on of apoptosis by an t i -APO-1 . 
Express i on of the ant igen a n d sensit iv i ty to the induc t i on of 
cel l death by ant i -APO-1 were s tud ied i n h u m a n T-cel l l ines 
transformed by h u m a n l eukemia v i rus type 1 (HTLV-1 ) a n d i n 
cu l tured cells from pat ients w i th ATL . APO-1 was strongly ex-
pressed on bo th types of cells, a n d incuba t i on of the cells w i th 
ant i -APO-1 resul ted i n inh ib i t i on of prol i ferat ion a n d apopto-
s is . Induct ion of apoptosis may therefore be a therapeutic tool 
i n HTLV-1-assoc ia ted mal ignant disorders (Debatin et a l . 
1990). 
Expression of the APO-1 phenotype in BurkitVs lymphoma cell 
lines correlates with a phenotype shift to a lymphoblastoid phe-
notype. We h a d previously found that APO-1 was also ex-
pressed on norma l activated B cells (Trauth et a l . 1989). F u r -
thermore, a sma l l subset of follicle center B cells res id ing at a 
locat ion i n w h i c h matura t i on , prol i ferat ion, a n d e l iminat ion by 
apoptosis of B cells takes place h a d been shown by i m m u n o -
his tochemistry to be A P O - l + . Therefore, we tested whether 
mal ignant counterparts of s u c h germina l center B cel ls, 
Burk i t t ' s l y m p h o m a (BL) cells, expressed APO-1 a n d were 
sensitive to an t i -APO-1- induced apoptosis. Tak ing together the 
evaluat ion of a large number of tests of B L cells a n d B L l ines 
phenotypical ly resembl ing i n vivo B L a n d cel l l ines showing a 
phenotype of Eps t e in -Bar r v irus-posit ive l ymphoblas to id cells 
(LCL), the fol lowing resul ts were obtained. B L cells direct ly iso-
lated from tumor biopsies were A P O - 1 " . B L type cel l l ines were 
A P O - 1 " , a n d L C L type cel l l ines were A P O - 1 + . Ce l ls of the 
B L / L C L phenotype showed a heterogeneous A P O - 1 + pat tern. 
Some bu t not a l l cells of the A P O - 1 + phenotype were sensit ive 
to an t i -APO-1- induced apoptosis. The phenotypic shift of B L 
cel l l ines may correlate w i th the one i n B-ce l l act ivat ion. 
Therefore, these cel l l ines may represent a use fu l system to 
s tudy APO-1 expression a n d funct ion i n B cel ls. 
Expression of the APO-1 antigen on glioblastoma cell lines and 
their susceptibility to apoptosis. To assess the potent ia l use fu l -
ness of ant i -APO-1 for therapy i n other tumor systems, we also 
tested h u m a n g l iob lastoma cel l l ines for expression of the 
APO-1 ant igen a n d suscept ib i l i ty to an t i -APO-1- induced apop-
tosis. Mos t cel l l ines expressed APO-1 at least at a low level. 
Some cel l l ines showed growth inh ib i t i on a n d apoptosis i f i n -
cubated w i th an t i -APO-1 . Thus , a l though APO-1 was ex-
pressed on most cel l l ines tested, only a few responded to an t i -
A P O - 1 . Subc l on ing a part ia l ly responsive cel l l ine yie lded 
A P O - 1 + , ant i -APO-1-sensi t ive a n d APO-1 \ ant i -APO-1-res is -
tant subclones. The da ta i n th is ce l lu lar system, therefore, 
stress again that express ion of the APO-1 ant igen a n d a n i n -
tact apoptosis s igna l pathway are necessary for success fu l 
ant i -APO-1-mediated apoptosis. Presently, we are invest igat ing 
w h i c h parameters determine the suscept ib i l i ty of s u c h clones 
to induc t i on of apoptosis, a n d whether loca l ant i -APO-1 
therapy might be considered i n s u c h a disease where surv iva l 
after relapse is short a n d no therapeut ic possibi l i t ies exist. 
APO-1 expression in colorectal carcinomas correlates with poor 
prognosis. A l l above data on var ious mal ignant cells show a 
c ommon trait. APO-1 express ion on the same type of tumor 
varies. In addi t ion , s imi lar var iab i l i ty is observed as to suscep-
t ibi l i ty to an t i -APO-1- induced apoptosis on A P O - 1 + ma l ignant 
cel ls. Tumors are either sensit ive, res istant , or composed of 
sensitive a n d res istant cel ls. Th is observat ion also extends to 
sarcomas a n d m a m m a r y carc inomas not extensively d i scussed 
here. A l though the physio log ical funct ion of APO-1 is s t i l l u n -
clear, one may speculate that the observed heterogeneity is 
meaningful for the biology of the tumor a n d thus also for the 
c l in i ca l course of the mal ignant disease. These considerat ions 
led u s to investigate APO-1 express ion on colorectal car-
c inomas a n d to correlate our findings w i th the c l in i ca l parame-
ters of this mal ignant disease. 
B y means of immunoh is tochemis t ry , we found that APO-1 
is expressed i n no rma l co lon ep i the l ium. In a m inor fract ion of 
co lon adenomas a n d i n 39 .6% of colorectal carc inomas , how-
ever, APO-1 express ion was d im in i shed . In 4 8 . 3 % of car-
c inomas, predominant ly of the n o n m u c i n o u s type, APO-1 was 
completely abrogated. The no rma l level of APO-1 expression i n 
ca rc inoma was correlated w i th the m u c i n o u s type (p<0.0001). 
Reduced or lost ant igen express ion was more frequent i n carc i -
nomas local ized i n the r e c tum (p<0.0001). In a group of 149 
pat ients who h a d undergone potential ly curat ive surgery for 
colorectal carc inoma, the physio log ical level of APO-1 expres-
s ion was correlated w i th a shorter surv iva l after relapse (p = 
0.031) a n d w i th a n increased r i sk of tumor-re lated death (p = 
0.051) (P. Möller et a l . , i n prep.). Th is suggested that the A P O -
1 ant igen is impor tant for s ignals i n growth contro l of n o r m a l 
a n d mal ignant cel ls. Thus , APO-1 may confer growth advan-
tage to mal ignant cells a n d determine the grade of mal ignancy . 
Fur thermore , th is first set of c l in i ca l data underscores the i m -
portance of APO-1 test ing a n d corre lat ion w i th pat ient h is to-
ries i n other mal ignancies . Th is appl ies par t i cu lar ly to those i n 
w h i c h heterogeneous APO-1 express ion is already observed. It 
w o u l d not be su rp r i s ing if the APO-1 ant igen also const i tuted 
a va luable prognostic parameter i n s u c h diseases. 
DISCUSSION AND OUTLOOK 
We showed that ant i -APO-1 specif ical ly b locked growth a n d 
triggered programmed cel l death, apoptosis, of a set of ac-
tivated no rma l lymphocytes a n d cells from mal ignant l ympho id 
a n d non l ympho id l ines after b ind ing to the cel l-surface prote in 
ant igen A P O - 1 . The APO-1 ant igen does not seem to be part of 
the T N F receptor complex, s ince its representat ion on the sur -
face of var ious cells does not correspond to the d i s t r ibut i on of 
T N F receptors; i.e., macrophage cel l l ines tested so far are 
A P O - 1 " . Nevertheless, it w i l l be important to test whether var i -
ous apoptosis pathways s u c h as the one triggered by T N F a n d 
ant i -APO-1 have c ommon features. 
Apoptos is is f ound i n a l l t i ssues a n d also i n cells from lower 
organisms. It is conceivable, therefore, that several d is t inct 
cel l-surface antigens w i th a different t issue d i s t r ibut i on are i n -
volved i n the induc t i on of apoptosis. E luc i da t i on of the s t ruc-
ture of A P O - 1 , its possible connect ion to the cytoskeleton, a n d 
the molecular events fol lowing ant i -APO-1 b ind ing may resolve 
some of these issues . 
S ince APO-1 is expressed on mature activated lymphocytes, 
addi t iona l experiments w i l l be needed to determine whether 
the ant igen might p lay a role i n the down-regulat ion of the i m -
m u n e response a n d be involved i n selection a n d e l iminat ion of 
lymphocytes. It has prev iously been shown that LT, TNF , and 
ki l ler cel ls w i th their effector molecules induce apoptotic cel l 
death. Because ant i -APO-1 also induces apoptosis, a number 
of possibi l i t ies might be considered for the physio log ical role of 
the APO-1 ant igen. APO-1 might be a receptor for cytotoxic 
molecules or for autocr ine growth factors. Alternatively, it 
cou ld be a molecule essent ia l for vert ical or lateral growth sig-
n a l t ransduct i on . Thus , ant i -APO-1 might trigger receptors for 
lytic molecules or b lock receptors for growth s ignals. Putative 
s ignals given by APO-1 may r ema in a n en igma u n t i l the s t ruc -
ture of the ant igen reveals its secrets. In any case, the e luc ida-
t ion of the APO-1-media ted apoptosis pathway wi l l const i tute 
a challenge for our research a n d w i l l provide a bas is for the 
development of a ra t iona l intervent ion strategy i n var ious d is-
eases, par t i cu lar ly cancer. 
O u r data also have c l in i ca l relevance. Ant i -APO-1 may be 
use fu l as a diagnostic tool to define subsets of no rma l a n d 
mal ignant lymphocytes a n d other tumor types. In addi t ion, i n -
duc t i on of apoptosis may have impl icat ions for ant i tumor ther-
apy. Ant ibodies have frequently been used as heteroconjugates 
w i th toxins or drugs to destroy tumor cel ls. O u r data, however, 
show that monoc lona l ant ibodies alone can be le thal to target 
cel ls, provided these cells express APO-1 a n d have a n intact 
apoptosis pathway. Ant i -APO-1 might, therefore, be considered 
for ex vivo or i n vivo therapy, under condi t ions where reactivity 
w i th v i ta l no rma l cells c an be exc luded or tolerated. Thus , i n 
the immediate future, careful toxicity studies i n SC ID mice 
reconst i tuted w i th a h u m a n i m m u n e system, i n pr imates, a n d 
i n pat ients w i l l be necessary. 
It is easily imagined that a success fu l putat ive ant i -APO-1 
therapy might go beyond a therapy of cancer a n d might i n -
volve e l iminat ion by apoptosis, e.g., of act ivated lymphocytes 
i n au to immune diseases. It shou ld also be considered that 
apoptosis may be involved i n the pa thomechan i sm of the e l im-
inat ion of T-helper lymphocytes i n A IDS , a process that is s t i l l 
largely not understood. In th is context, we tested the presence 
of A P O - l + lymphocytes a n d of ant i -APO-1 autoant ibodies i n 
A IDS . We found the numbe r of A P O - l + cells increased i n H I V + 
donors. In addi t ion , i n the s e rum of H I V + donors, ant i -APO-1 
autoant ibodies were detected. These findings may suggest a 
role for apoptosis i n the deplet ion of T cells i n A I D S a n d clearly 
warrant further studies . 
F ina l ly , the molecular invest igat ion of cel l death induced by 
ant i -APO-1 might lead to a general unde rs tand ing of apop-
tosis. In this case, the use of modif ied or normad physio log ical 
l igands to the cel l-surface ant igen in i t ia t ing apoptosis or of 
chemica ls interfering w i th the apoptotic s ignal might be en-
visaged. 
Taken together, the APO-1 apoptosis system might help to 
find "death genes" a n d clarify whether death occurs i n steps, 
is a s ingle-hit event, or c an be reversed once its in i t i a l s ignals 
are triggered. Thus , the invest igat ion of apoptosis shows that 
essent ial quest ions of death are l i nked a n d c a n be as exci t ing 
as the essent ia l quest ions of life. 
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